S-adenosylmethionine: Difference between revisions
Jump to navigation
Jump to search
imported>Robert Badgett No edit summary |
imported>Daniel Mietchen (+subpages) |
||
| Line 1: | Line 1: | ||
{{subpages}} | |||
In [[biology]] and [[medicine]], '''S-adenosylmethionine''' is a "physiologic methyl radical donor involved in enzymatic transmethylation reactions and present in all living organisms. It possesses anti-inflammatory activity and has been used in treatment of chronic liver disease."<ref>{{MeSH}}</ref> | In [[biology]] and [[medicine]], '''S-adenosylmethionine''' is a "physiologic methyl radical donor involved in enzymatic transmethylation reactions and present in all living organisms. It possesses anti-inflammatory activity and has been used in treatment of chronic liver disease."<ref>{{MeSH}}</ref> | ||
Revision as of 04:37, 24 April 2009
In biology and medicine, S-adenosylmethionine is a "physiologic methyl radical donor involved in enzymatic transmethylation reactions and present in all living organisms. It possesses anti-inflammatory activity and has been used in treatment of chronic liver disease."[1]
S-adenosylmethionine's role in treating liver disease is uncertain.[2]
S-adenosylmethionine may help osteoarthritis[3][4][5][6][7]; however, the limited research may be affected by publication bias.
References
- ↑ Anonymous (2024), S-adenosylmethionine (English). Medical Subject Headings. U.S. National Library of Medicine.
- ↑ Rambaldi A, Gluud C (2006). "S-adenosyl-L-methionine for alcoholic liver diseases". Cochrane Database Syst Rev (2): CD002235. DOI:10.1002/14651858.CD002235.pub2. PMID 16625556. Research Blogging.
- ↑ Hardy ML, Coulter I, Morton SC, et al (August 2003). "S-adenosyl-L-methionine for treatment of depression, osteoarthritis, and liver disease". Evid Rep Technol Assess (Summ) (64): 1–3. PMID 12899148. [e] ACP Journal Club review
- ↑ Najm WI, Reinsch S, Hoehler F, Tobis JS, Harvey PW (February 2004). "S-adenosyl methionine (SAMe) versus celecoxib for the treatment of osteoarthritis symptoms: a double-blind cross-over trial. [ISRCTN36233495"]. BMC Musculoskelet Disord 5: 6. DOI:10.1186/1471-2474-5-6. PMID 15102339. PMC 387830. Research Blogging.
- ↑ Müller-Fassbender H (November 1987). "Double-blind clinical trial of S-adenosylmethionine versus ibuprofen in the treatment of osteoarthritis". Am. J. Med. 83 (5A): 81–3. PMID 3318445. [e]
- ↑ Vetter G (November 1987). "Double-blind comparative clinical trial with S-adenosylmethionine and indomethacin in the treatment of osteoarthritis". Am. J. Med. 83 (5A): 78–80. PMID 3318444. [e]
- ↑ König B (November 1987). "A long-term (two years) clinical trial with S-adenosylmethionine for the treatment of osteoarthritis". Am. J. Med. 83 (5A): 89–94. PMID 3318447. [e]